{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:43:11Z","timestamp":1782783791681,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1124\/jpet.118.247908","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T19:35:11Z","timestamp":1528486511000},"page":"390-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of ASP6432, a Novel Type 1 Lysophosphatidic Acid Receptor Antagonist, on Urethral Function and Prostate Cell Proliferation"],"prefix":"10.1016","volume":"366","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6974-2454","authenticated-orcid":false,"given":"Kazuyuki","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ueshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamakuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hosogai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kawaminami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.247908_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pros.10077","article-title":"Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: sildenafil and papaverin generate inhibition","volume":"51","author":"Adolfsson","year":"2002","journal-title":"Prostate"},{"key":"10.1124\/jpet.118.247908_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-3565(24)35074-8","article-title":"KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model","volume":"291","author":"Akiyama","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.247908_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-5347(17)56476-9","article-title":"Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia","volume":"122","author":"Bartsch","year":"1979","journal-title":"J Urol"},{"key":"10.1124\/jpet.118.247908_bib4","doi-asserted-by":"crossref","first-page":"e85348","DOI":"10.1371\/journal.pone.0085348","article-title":"1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats","volume":"9","author":"Castilla-Ortega","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.247908_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: subtypes and biological actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.118.247908_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1388-1981(02)00180-4","article-title":"Mitogenic action of LPA in prostate","volume":"1582","author":"Daaka","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.118.247908_bib7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1096\/fj.201600735R","article-title":"LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction","volume":"31","author":"Dancs","year":"2017","journal-title":"FASEB J"},{"issue":"3","key":"10.1124\/jpet.118.247908_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0090-4295(03)00589-2","article-title":"Lower urinary tract symptoms\/benign prostatic hyperplasia: fast control of the patient\u2019s quality of life","volume":"62","author":"Djavan","year":"2003","journal-title":"Urology"},{"key":"10.1124\/jpet.118.247908_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.118.247908_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2009.10.006","article-title":"The physiological function of lower urinary tract smooth muscle","volume":"154","author":"Fry","year":"2010","journal-title":"Auton Neurosci"},{"key":"10.1124\/jpet.118.247908_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/luts.12077","article-title":"Study on physiological roles of stimulation of prostaglandin E2 receptor subtype EP2 in urethral function in rats","volume":"8","author":"Kurihara","year":"2016","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1124\/jpet.118.247908_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.01.004","article-title":"Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox","volume":"58","author":"Llona-Minguez","year":"2015","journal-title":"Prog Lipid Res"},{"key":"10.1124\/jpet.118.247908_bib13","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/S0022-5347(01)64707-4","article-title":"Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia","volume":"157","author":"Marks","year":"1997","journal-title":"J Urol"},{"key":"10.1124\/jpet.118.247908_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2017.08.032","article-title":"Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents","volume":"126","author":"Murai","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.118.247908_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejphar.2004.06.066","article-title":"Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia","volume":"497","author":"Ohtake","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.247908_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2006.06.054","article-title":"Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure","volume":"545","author":"Ohtake","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.247908_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.eururo.2004.04.009","article-title":"The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women","volume":"46","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.118.247908_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.pcan.4500849","article-title":"Three months\u2019 treatment with the alpha1-blocker alfuzosin does not affect total or transition zone volume of the prostate","volume":"9","author":"Roehrborn","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl 3","key":"10.1124\/jpet.118.247908_bib19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ijir.2008.55","article-title":"Pathology of benign prostatic hyperplasia","volume":"20","author":"Roehrborn","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1124\/jpet.118.247908_bib20","doi-asserted-by":"crossref","first-page":"e93230","DOI":"10.1371\/journal.pone.0093230","article-title":"A novel highly potent autotaxin\/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension","volume":"9","author":"Saga","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.247908_bib21","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1210\/en.2003-1350","article-title":"Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid","volume":"145","author":"Sakamoto","year":"2004","journal-title":"Endocrinology"},{"issue":"Suppl 4","key":"10.1124\/jpet.118.247908_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000049891","article-title":"Initial choices and final outcomes in lower urinary tract symptoms","volume":"40","author":"Speakman","year":"2001","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.118.247908_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2680.1996.tb00004.x","article-title":"Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs","volume":"16","author":"Sudoh","year":"1996","journal-title":"J Auton Pharmacol"},{"key":"10.1124\/jpet.118.247908_bib24","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1476-5381.2010.00828.x","article-title":"A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model","volume":"160","author":"Swaney","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.247908_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.febslet.2004.06.083","article-title":"Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma","volume":"571","author":"Tanaka","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.118.247908_bib26","doi-asserted-by":"crossref","first-page":"25822","DOI":"10.1074\/jbc.M605142200","article-title":"Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid","volume":"281","author":"Tanaka","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.247908_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1021\/acsmedchemlett.6b00225","article-title":"Discovery of ONO-7300243 from a novel class of lysophosphatidic acid receptor 1 antagonists: from hit to lead","volume":"7","author":"Terakado","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/jpet.118.247908_bib28","first-page":"74","article-title":"Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregant rats","volume":"245","author":"Tokumura","year":"1980","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/jpet.118.247908_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1074\/jbc.M210151200","article-title":"Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1","volume":"278","author":"Van Leeuwen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.247908_bib30","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/bph.13099","article-title":"Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864","volume":"172","author":"Wang","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.247908_bib31","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1074\/jbc.M113.533042","article-title":"Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration","volume":"289","author":"Wu","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.247908_bib32","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.118.247908_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/pros.20879","article-title":"Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia","volume":"69","author":"Zeng","year":"2009","journal-title":"Prostate"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.247908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T01:45:11Z","timestamp":1751679911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524262224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0022356524262224"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.247908","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ASP6432, a Novel Type 1 Lysophosphatidic Acid Receptor Antagonist, on Urethral Function and Prostate Cell Proliferation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.247908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}